BAUPOST GROUP LLC 13D and 13G filings for Theravance Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-09-09 5:42 pm Sale | 2024-08-31 | 13G | Theravance Biopharma, Inc. TBPH | BAUPOST GROUP LLC | 0 0.000% | -2,977,304 (Position Closed) | Filing |
| 2024-08-09 4:14 pm Sale | 2024-07-31 | 13G | Theravance Biopharma, Inc. TBPH | BAUPOST GROUP LLC | 2,977,304 6.120% | -4,441,922 (-59.87%) | Filing |
| 2023-07-10 4:33 pm Sale | 2023-06-30 | 13G | Theravance Biopharma, Inc. TBPH | BAUPOST GROUP LLC | 7,419,226 12.840% | -4,000,000 (-35.03%) | Filing |
| 2023-02-13 4:41 pm Sale | 2023-02-13 | 13G | Theravance Biopharma, Inc. TBPH | BAUPOST GROUP LLC | 11,419,226 16.950% | -3,111,770 (-21.41%) | Filing |
| 2022-02-11 4:15 pm Purchase | 2022-02-11 | 13G | Theravance Biopharma, Inc. TBPH | BAUPOST GROUP LLC | 14,530,996 19.490% | 4,925,000 (+51.27%) | Filing |
| 2021-02-12 4:26 pm Sale | 2021-02-12 | 13G | Theravance Biopharma, Inc. TBPH | BAUPOST GROUP LLC | 9,605,996 14.810% | -574,000 (-5.64%) | Filing |